197 related articles for article (PubMed ID: 30042406)
1. In vivo delineation of glioblastoma by targeting tumor-associated macrophages with near-infrared fluorescent silica coated iron oxide nanoparticles in orthotopic xenografts for surgical guidance.
Lee C; Kim GR; Yoon J; Kim SE; Yoo JS; Piao Y
Sci Rep; 2018 Jul; 8(1):11122. PubMed ID: 30042406
[TBL] [Abstract][Full Text] [Related]
2. Near Infrared Fluorescent Nanoplatform for Targeted Intraoperative Resection and Chemotherapeutic Treatment of Glioblastoma.
Reichel D; Sagong B; Teh J; Zhang Y; Wagner S; Wang H; Chung LWK; Butte P; Black KL; Yu JS; Perez JM
ACS Nano; 2020 Jul; 14(7):8392-8408. PubMed ID: 32551496
[TBL] [Abstract][Full Text] [Related]
3. First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using
Li D; Zhang J; Chi C; Xiao X; Wang J; Lang L; Ali I; Niu G; Zhang L; Tian J; Ji N; Zhu Z; Chen X
Theranostics; 2018; 8(9):2508-2520. PubMed ID: 29721096
[No Abstract] [Full Text] [Related]
4. Peptide-guided nanoparticles for glioblastoma targeting.
Säälik P; Lingasamy P; Toome K; Mastandrea I; Rousso-Noori L; Tobi A; Simón-Gracia L; Hunt H; Paiste P; Kotamraju VR; Bergers G; Asser T; Rätsep T; Ruoslahti E; Bjerkvig R; Friedmann-Morvinski D; Teesalu T
J Control Release; 2019 Aug; 308():109-118. PubMed ID: 31255690
[TBL] [Abstract][Full Text] [Related]
5. TSPO-targeted NIR-fluorescent ultra-small iron oxide nanoparticles for glioblastoma imaging.
Denora N; Lee C; Iacobazzi RM; Choi JY; Song IH; Yoo JS; Piao Y; Lopalco A; Leonetti F; Lee BC; Kim SE
Eur J Pharm Sci; 2019 Nov; 139():105047. PubMed ID: 31422171
[TBL] [Abstract][Full Text] [Related]
6. Theranostic Application of Mixed Gold and Superparamagnetic Iron Oxide Nanoparticle Micelles in Glioblastoma Multiforme.
Sun L; Joh DY; Al-Zaki A; Stangl M; Murty S; Davis JJ; Baumann BC; Alonso-Basanta M; Kaol GD; Tsourkas A; Dorsey JF
J Biomed Nanotechnol; 2016 Feb; 12(2):347-56. PubMed ID: 27305768
[TBL] [Abstract][Full Text] [Related]
7. An Advanced
Chan MH; Chen W; Li CH; Fang CY; Chang YC; Wei DH; Liu RS; Hsiao M
ACS Appl Mater Interfaces; 2021 Jun; 13(23):26759-26769. PubMed ID: 34076419
[TBL] [Abstract][Full Text] [Related]
8. Scaffolds biomimicking macrophages for a glioblastoma NIR-Ib imaging guided photothermal therapeutic strategy by crossing Blood-Brain Barrier.
Lai J; Deng G; Sun Z; Peng X; Li J; Gong P; Zhang P; Cai L
Biomaterials; 2019 Aug; 211():48-56. PubMed ID: 31085358
[TBL] [Abstract][Full Text] [Related]
9. Real-time multi-modality imaging of glioblastoma tumor resection and recurrence.
Hingtgen S; Figueiredo JL; Farrar C; Duebgen M; Martinez-Quintanilla J; Bhere D; Shah K
J Neurooncol; 2013 Jan; 111(2):153-61. PubMed ID: 23242736
[TBL] [Abstract][Full Text] [Related]
10. Molecular Targeted NIR-II Probe for Image-Guided Brain Tumor Surgery.
Kurbegovic S; Juhl K; Chen H; Qu C; Ding B; Leth JM; Drzewiecki KT; Kjaer A; Cheng Z
Bioconjug Chem; 2018 Nov; 29(11):3833-3840. PubMed ID: 30296054
[TBL] [Abstract][Full Text] [Related]
11. EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.
Hadjipanayis CG; Machaidze R; Kaluzova M; Wang L; Schuette AJ; Chen H; Wu X; Mao H
Cancer Res; 2010 Aug; 70(15):6303-12. PubMed ID: 20647323
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence.
Oudin A; Moreno-Sanchez PM; Baus V; Niclou SP; Golebiewska A
BMC Cancer; 2024 Jan; 24(1):3. PubMed ID: 38166949
[TBL] [Abstract][Full Text] [Related]
13. IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts.
Kurbegovic S; Juhl K; Sørensen KK; Leth J; Willemoe GL; Christensen A; Adams Y; Jensen AR; von Buchwald C; Skjøth-Rasmussen J; Ploug M; Jensen KJ; Kjaer A
Theranostics; 2021; 11(15):7159-7174. PubMed ID: 34158842
[TBL] [Abstract][Full Text] [Related]
14. Identify a Blood-Brain Barrier Penetrating Drug-TNB using Zebrafish Orthotopic Glioblastoma Xenograft Model.
Zeng A; Ye T; Cao D; Huang X; Yang Y; Chen X; Xie Y; Yao S; Zhao C
Sci Rep; 2017 Oct; 7(1):14372. PubMed ID: 29085081
[TBL] [Abstract][Full Text] [Related]
15. In vivo MRI detection of intraplaque macrophages with biocompatible silica-coated iron oxide nanoparticles in murine atherosclerosis.
Kim CW; Hwang BH; Moon H; Kang J; Park EH; Ihm SH; Chang K; Hong KS
J Appl Biomater Funct Mater; 2021; 19():22808000211014751. PubMed ID: 34520279
[TBL] [Abstract][Full Text] [Related]
16. Transferrin receptor 1 targeted optical imaging for identifying glioma margin in mouse models.
Ni XR; Zhao YY; Cai HP; Yu ZH; Wang J; Chen FR; Yu YJ; Feng GK; Chen ZP
J Neurooncol; 2020 Jun; 148(2):245-258. PubMed ID: 32405996
[TBL] [Abstract][Full Text] [Related]
17. Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment.
Pinel S; Thomas N; Boura C; Barberi-Heyob M
Adv Drug Deliv Rev; 2019 Jan; 138():344-357. PubMed ID: 30414495
[TBL] [Abstract][Full Text] [Related]
18. A gain of function paradox: Targeted therapy for glioblastoma associated with abnormal NHE9 expression.
Pall AE; Juratli L; Guntur D; Bandyopadhyay K; Kondapalli KC
J Cell Mol Med; 2019 Nov; 23(11):7859-7872. PubMed ID: 31532058
[TBL] [Abstract][Full Text] [Related]
19. Locoregional Confinement and Major Clinical Benefit of
Séhédic D; Chourpa I; Tétaud C; Griveau A; Loussouarn C; Avril S; Legendre C; Lepareur N; Wion D; Hindré F; Davodeau F; Garcion E
Theranostics; 2017; 7(18):4517-4536. PubMed ID: 29158842
[TBL] [Abstract][Full Text] [Related]
20. Radiosensitivity enhancement of radioresistant glioblastoma by epidermal growth factor receptor antibody-conjugated iron-oxide nanoparticles.
Bouras A; Kaluzova M; Hadjipanayis CG
J Neurooncol; 2015 Aug; 124(1):13-22. PubMed ID: 25981803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
